China has given conditional approval to a coronavirus vaccine developed by state-owned Sinopharm.The vaccine is the first one approved for general use in China.Chen Shifei, the deputy commissioner of China’s National Medical Products Administration, said at a news conference Thursday that the decision had been made the previous night.
Canada still awaiting data from AstraZeneca as U.K. approves new coronavirus vaccine The vaccine is an inactivated, two-dose vaccine from the Beijing Institute of Biological Products, a subsidiary of state-owned conglomerate Sinopharm.
The company announced Wednesday that preliminary data from last-stage trials had shown it to be 79.3 per cent effective.[ Sign up for our Health IQ newsletter for the latest.